Low oxygen in prostate tumors is strongly predictive of relapse after therapy [45], illustrating the need to identify novel treatment strategies that target hypoxic tumor cells, and the HIF-1α protein that modulates the cellular hypoxic response. Here, HIF1A is linked to prostate neoplasm.